• Keine Ergebnisse gefunden

Topiramate – and risk of congenital malformations Final SmPC and PL wording agreed by the PhVWP in January 2012

N/A
N/A
Protected

Academic year: 2022

Aktie "Topiramate – and risk of congenital malformations Final SmPC and PL wording agreed by the PhVWP in January 2012"

Copied!
1
0
0

Wird geladen.... (Jetzt Volltext ansehen)

Volltext

(1)

Topiramate – and risk of congenital malformations January 2012 Page 1/1

Topiramate – and risk of congenital malformations

Final SmPC and PL wording agreed by the PhVWP in January 2012

Doc.Ref.: CMDh/PhVWP/040/2012 January 2012

USUMMARY OF PRODUCT CHARACTERISTICS 4.6 Fertility, pregnancy and lactation

(…)

Data from the U.K. pregnancy register and the North American Antiepileptic Drug (NAAED) pregnancy registry indicate that infants exposed to topiramate monotherapy in the first trimester have an increased risk of congenital malformations (e.g., craniofacial defects, such as cleft lip/palate, hypospadias, and anomalies involving various body systems). The NAAED pregnancy registry data for topiramate monotherapy showed an approximate 3-fold higher incidence of major congenital malformations, compared with a reference group not taking antiepileptic drugs.

Furthermore, there was a higher prevalence of low birth weight (<2500 grams) following topiramate treatment than in the reference group.

(…)

Referenzen

ÄHNLICHE DOKUMENTE

Caution should be advised in patients receiving concomitant medications which could increase the risk of ulceration or bleeding, such as oral corticosteroids, anticoagulants such

In an epidemiological study using a UK database, the risk of VTE in association with tibolone was lower than the risk associated with conventional HRT, but only a small proportion

Oral Methotrexate – Review on potential fatal January 2012 Page 1/1 overdose due to medication errors.. Oral Methotrexate – Review on potential fatal overdose due to medication

There have been reports of decreased bone mineral density, osteopenia, osteoporosis and fractures in patients on long-term therapy with [drug name]. The mechanism by which [drug

Acne fulminans, acne aggravated (acne flare), erythema (facial), exanthema, hair disorders, hirsutism, nail dystrophy, paronychia, photosensitivity reaction, pyogenic granuloma,

Acute poisoning was observed after significant accidental consumption, with nausea, vomiting, abdominal pain, and headache, vertigo, feeling hot / flushing, convulsions,

Section 4.5 Interaction with other medicinal products and other forms of interaction Decreases in blood levels of valproic acid have been reported when it is co-administered

Some cases of severe liver reactions, including cases with fatal outcome or requiring liver transplant, have been reported in both children and adults treated with